-
1
-
-
34447563811
-
Thrombokinase as a prime activator of prothrombin: Historical perspectives and present status
-
Milstone JH. Thrombokinase as a prime activator of prothrombin: historical perspectives and present status. Fed Proc. 1964;23:742-748.
-
(1964)
Fed Proc
, vol.23
, pp. 742-748
-
-
Milstone, J.H.1
-
2
-
-
0030858413
-
Coagulation factor V: An old star shines again
-
Rosing J, Tans G. Coagulation factor V: an old star shines again. Thromb Haemost. 1997;78:427-433.
-
(1997)
Thromb Haemost
, vol.78
, pp. 427-433
-
-
Rosing, J.1
Tans, G.2
-
3
-
-
0242585716
-
Blood coagulation
-
Dahlbäck B. Blood coagulation. Lancet. 2000;355:1627-1632.
-
(2000)
Lancet
, vol.355
, pp. 1627-1632
-
-
Dahlbäck, B.1
-
4
-
-
85184363008
-
-
Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood. 2003;101:20-30.
-
Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood. 2003;101:20-30.
-
-
-
-
5
-
-
0020320628
-
Thrombin-catalyzed activation of human coagulation factor V
-
Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem. 1982;257:6556-6564.
-
(1982)
J Biol Chem
, vol.257
, pp. 6556-6564
-
-
Suzuki, K.1
Dahlbäck, B.2
Stenflo, J.3
-
7
-
-
0019475805
-
Molecular weight of undegraded plasma factor V
-
Mann KG, Nesheim ME, Tracy PB. Molecular weight of undegraded plasma factor V. Biochemistry. 1981;20:28-33.
-
(1981)
Biochemistry
, vol.20
, pp. 28-33
-
-
Mann, K.G.1
Nesheim, M.E.2
Tracy, P.B.3
-
8
-
-
0019862464
-
Purification and characterization of human coagulation factor V
-
Kane WH, Majerus PW. Purification and characterization of human coagulation factor V. J Biol Chem. 1981;256:1002-1007.
-
(1981)
J Biol Chem
, vol.256
, pp. 1002-1007
-
-
Kane, W.H.1
Majerus, P.W.2
-
9
-
-
0026755597
-
Structure of the gene for human coagulation factor V
-
Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry. 1992;31:3777-3785.
-
(1992)
Biochemistry
, vol.31
, pp. 3777-3785
-
-
Cripe, L.D.1
Moore, K.D.2
Kane, W.H.3
-
10
-
-
0019977242
-
Radioimmunoassay of factor V in human plasma and platelets
-
Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood. 1982;60:59-63.
-
(1982)
Blood
, vol.60
, pp. 59-63
-
-
Tracy, P.B.1
Eide, L.L.2
Bowie, E.J.3
Mann, K.G.4
-
11
-
-
10444286053
-
Human platelets contain forms of factor V in disulfide-linkage with multimerin
-
Hayward CP, Fuller N, Zheng S, et al. Human platelets contain forms of factor V in disulfide-linkage with multimerin. Thromb Haemost. 2004;92:1349-1357.
-
(2004)
Thromb Haemost
, vol.92
, pp. 1349-1357
-
-
Hayward, C.P.1
Fuller, N.2
Zheng, S.3
-
12
-
-
0023203518
-
Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats
-
Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry. 1987;26:6508-6514.
-
(1987)
Biochemistry
, vol.26
, pp. 6508-6514
-
-
Kane, W.H.1
Ichinose, A.2
Hagen, F.S.3
Davie, E.W.4
-
13
-
-
0008912897
-
Complete cDNA and derived amino acid sequence of human Factor V
-
Jenny RJ, Pittman DD, Toole JJ, et al. Complete cDNA and derived amino acid sequence of human Factor V. Proc Natl Acad Sci U S A. 1987;84:4846-4850.
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 4846-4850
-
-
Jenny, R.J.1
Pittman, D.D.2
Toole, J.J.3
-
14
-
-
0021046120
-
The factor Xa-catalyzed activation of factor V
-
Foster WB, Nesheim ME, Mann KG. The factor Xa-catalyzed activation of factor V. J Biol Chem. 1983;258:13970-13977.
-
(1983)
J Biol Chem
, vol.258
, pp. 13970-13977
-
-
Foster, W.B.1
Nesheim, M.E.2
Mann, K.G.3
-
15
-
-
0021329431
-
Biosynthesis of coagulation factor V by a human hepatocellular carcinoma cell line
-
Wilson DB, Salem HH, Mruk JS, Maruyama I, Majerus PW. Biosynthesis of coagulation factor V by a human hepatocellular carcinoma cell line. J Clin Invest. 1984;73:654-658.
-
(1984)
J Clin Invest
, vol.73
, pp. 654-658
-
-
Wilson, D.B.1
Salem, H.H.2
Mruk, J.S.3
Maruyama, I.4
Majerus, P.W.5
-
16
-
-
0008237468
-
The coagulation of blood: Investigations on a new clotting factor
-
Owren PA. The coagulation of blood: investigations on a new clotting factor. Acta Med Scand. 1947;194(Suppl):1-7.
-
(1947)
Acta Med Scand
, vol.194
, Issue.SUPPL.
, pp. 1-7
-
-
Owren, P.A.1
-
18
-
-
0036456442
-
Two double heterozygous mutations in the F7 gene show different manifestations
-
Nagaizumi K, Inaba H, Suzuki T, et al. Two double heterozygous mutations in the F7 gene show different manifestations. Br J Haematol. 2002;119:1052-1058.
-
(2002)
Br J Haematol
, vol.119
, pp. 1052-1058
-
-
Nagaizumi, K.1
Inaba, H.2
Suzuki, T.3
-
19
-
-
38349080641
-
Congenital factor V deficiency and a mutation
-
Shinozawa K. Congenital factor V deficiency and a mutation. Jpn J Thromb Hemost. 2005;16:281-296.
-
(2005)
Jpn J Thromb Hemost
, vol.16
, pp. 281-296
-
-
Shinozawa, K.1
-
20
-
-
85184365178
-
-
Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999;96:307-310.
-
Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999;96:307-310.
-
-
-
-
21
-
-
0033082394
-
RNA surveillance: Unforeseen consequences for gene expression, inherited genetic disorders and cancer
-
Culbertson MR. RNA surveillance: unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet. 1999;15:74-80.
-
(1999)
Trends Genet
, vol.15
, pp. 74-80
-
-
Culbertson, M.R.1
-
22
-
-
0142183357
-
Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations
-
Montefusco MC, Duga S, Asselta R, et al. Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations. Blood. 2003;102:3210-3216.
-
(2003)
Blood
, vol.102
, pp. 3210-3216
-
-
Montefusco, M.C.1
Duga, S.2
Asselta, R.3
-
23
-
-
2942669901
-
The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cof actor function
-
Adams TE, Hockin MF, Mann KG, Everse SJ. The crystal structure of activated protein C-inactivated bovine factor Va: implications for cof actor function. Proc Natl Acad Sci U S A. 2004;101:8918-8923.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 8918-8923
-
-
Adams, T.E.1
Hockin, M.F.2
Mann, K.G.3
Everse, S.J.4
-
24
-
-
0029854371
-
Fatal hemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V
-
Cui J, O'Shea KS, Purkayastha A, Saunders TL, Ginsburg D. Fatal hemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature. 1996;384:66-68.
-
(1996)
Nature
, vol.384
, pp. 66-68
-
-
Cui, J.1
O'Shea, K.S.2
Purkayastha, A.3
Saunders, T.L.4
Ginsburg, D.5
-
25
-
-
0033978610
-
Rescue of fatal neonatal hemorrhage in factor V deficient mice by low transgene expression
-
Yang TL, Cui J, Taylor JM, Yang A, Gruber SB, Ginsburg D. Rescue of fatal neonatal hemorrhage in factor V deficient mice by low transgene expression. Thromb Haemost. 2000;83:70-77.
-
(2000)
Thromb Haemost
, vol.83
, pp. 70-77
-
-
Yang, T.L.1
Cui, J.2
Taylor, J.M.3
Yang, A.4
Gruber, S.B.5
Ginsburg, D.6
-
26
-
-
33745864802
-
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
-
Shi Q, Wilcox DA, Fahs SA, et al. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J Clin Invest. 2006;116:1974-1982.
-
(2006)
J Clin Invest
, vol.116
, pp. 1974-1982
-
-
Shi, Q.1
Wilcox, D.A.2
Fahs, S.A.3
|